homepagegheader_v1.jpg

Our Vision

Our vision is to heal patients and free them from the devastating effects of osteoarthritis by restoring hyaline cartilage and reducing inflammation using an evidence-based induced pluripotent stem cell (iPSC) derived hyaline cartilage cell therapy.

We are developing an off the shelf, injectable, regenerative therapy to delay or prevent the need for joint replacement.
Better Options Banner.png

The Problem

Osteoarthritis
One Million patients
3 million newly diagnosed
Economic Burden

SARCIO BELIEVES PATIENTS
DESERVE A BETTER OPTION.

Better Options Banner.png

Current Patient Pathway vs. the Sarcio Solution

Conservative measures like physical therapy, viscosupplementation (hyaluronic acid injections), and steroid injections may help in the short term. However, these measures often require joint replacements to relieve pain and enable joint function. Although total joint replacements can improve quality of life, recovery is long and painful, and implants only last 15-20 years. This forces many patients to choose between delaying surgery and having multiple surgeries on the same joint. Sarcio is developing an allogenic, iPSC-derived cartilage cell therapy to treat patients with osteoarthritis and delay or prevent the need for joint replacement.


Patient Path

Our Goals

• Reach patients as early as possible to delay or prevent surgery.

• Restore joint function, enabling patients to move without pain and anxiety.
Better Options Banner.png
 
 

Technology

Sarcio has developed a method to generate high-quality hyaline cartilage cells to provide restoration, regeneration, and repair.

About

Sarcio seeks a groundbreaking, regenerative therapy to restore normal joint function and improve the lives of patients suffering from osteoarthritis.